| Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy AS Astrup, L Tarnow, P Rossing, BV Hansen, J Hilsted, HH Parving Diabetes care 29 (2), 334-339, 2006 | 231 | 2006 |
| Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril SE Nielsen, KJ Schjoedt, AS Astrup, L Tarnow, M Lajer, PR Hansen, ... Diabetic Medicine 27 (10), 1144-1150, 2010 | 207 | 2010 |
| Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and … AS Astrup, L Tarnow, L Pietraszek, CG Schalkwijk, CDA Stehouwer, ... Diabetes Care 31 (6), 1170-1176, 2008 | 149 | 2008 |
| Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy WY Kim, AS Astrup, M Stuber, L Tarnow, E Falk, RM Botnar, C Simonsen, ... Circulation 115 (2), 228-235, 2007 | 140 | 2007 |
| Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study AS Astrup, FS Nielsen, P Rossing, S Ali, J Kastrup, UM Smidt, HH Parving Journal of hypertension 25 (12), 2479-2485, 2007 | 113 | 2007 |
| Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study SS Lund, L Tarnow, AS Astrup, P Hovind, PK Jacobsen, AC Alibegovic, ... PLoS One 3 (10), e3363, 2008 | 108 | 2008 |
| Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study AS Astrup, L Tarnow, P Rossing, L Pietraszek, PR Hansen, HH Parving Kidney international 68 (3), 1250-1257, 2005 | 105 | 2005 |
| Telomere length predicts all-cause mortality in patients with type 1 diabetes AS Astrup, L Tarnow, A Jorsal, M Lajer, R Nzietchueng, A Benetos, ... Diabetologia 53, 45-48, 2010 | 103 | 2010 |
| Tubular and glomerular injury in diabetes and the impact of ACE inhibition SE Nielsen, T Sugaya, L Tarnow, M Lajer, KJ Schjoedt, AS Astrup, T Baba, ... Diabetes Care 32 (9), 1684-1688, 2009 | 102 | 2009 |
| Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes SS Lund, L Tarnow, AS Astrup, P Hovind, PK Jacobsen, AC Alibegovic, ... Diabetes, Obesity and Metabolism 11 (10), 966-977, 2009 | 59 | 2009 |
| 40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004 M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ... Diabetologia 47, A1-A464, 2004 | 53 | 2004 |
| Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial KJ Schjoedt, AS Astrup, F Persson, E Frandsen, F Boomsma, K Rossing, ... Diabetologia 52, 46-49, 2009 | 48 | 2009 |
| Monitoring kidney function in diabetic nephropathy P Rossing, AS Astrup, UM Smidt, HH Parving Diabetologia 37, 708-712, 1994 | 47 | 1994 |
| Plasma α-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients G Joseph, L Tarnow, AS Astrup, TK Hansen, HH Parving, A Flyvbjerg, ... The Journal of Clinical Endocrinology & Metabolism 93 (4), 1470-1475, 2008 | 42 | 2008 |
| rössner s, van gaal l, et al A Astrup Effects of liraglutide in the treatment of obesity: a randomised …, 2009 | 41* | 2009 |
| Effect of sibutramine on weight maintenance after weight loss: a randomised trial W Philip, T James, A Astrup, N Finer, J Hilsted, P Kopelman, S Rössner, ... Lancet 356 (9248), 2119-2125, 2000 | 39 | 2000 |
| Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy L Tarnow, AS Astrup, HH Parving Scandinavian Journal of Clinical and Laboratory Investigation 65 (sup240), 73-79, 2005 | 26 | 2005 |
| Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis AS Astrup Dan Med Bull 58 (8), B4152, 2011 | 23 | 2011 |
| Goulder For The STORM Study Group M. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre … D Hansen, A Astrup, S Toubro, N Finer, P Kopelman, J Hilsted, S Rössner, ... Int J Obes Relat Metab Disord 25 (4), 496-501, 2001 | 18 | 2001 |
| Sibutramine Trial of Obesity Reduction and Maintenance (STORM) Study Group. Effect of sibutramine on weight maintenance after weight loss: a randomised trial WP James, A Astrup, N Finer, J Hilsted, P Kopelman, S Rossner, ... Lancet 356, 2119-2125, 2000 | 16 | 2000 |
